| Content-Type: |
text/plain; charset="us-ascii" |
| Date: |
Fri, 16 Nov 2012 17:11:59 +0100 |
| Reply-To: |
|
| Subject: |
|
| Content-Transfer-Encoding: |
quoted-printable |
| Message-ID: |
|
| MIME-Version: |
1.0 |
| Sender: |
"Moderated conference on GMOs in the pipeline,
hosted by the FAO Biotechnology Forum"
< [log in to unmask]> |
| From: |
|
| Parts/Attachments: |
|
|
This is Neha Saigal again, in response to Godelieve Gheysen (Message 28):
As I mentioned earlier (Message 27), India is the centre of origin and the centre of diversity for Brinjal and we have many wild and cultivated varieties. The vast wealth of plant genetic resource of brinjal have very important medicinal use in ayurveda (a traditional system of medicine in India). One of the major concerns when Bt Brinjal came up for commercialisation was the transgene flow from Bt Brinjal to wild and cultivated varieties thus contaminating the genome. The pest resistance transgene that is carried by Bt Brinjal will confer a selective advantage which might encourage weediness and invasiveness in wild relatives thereby reducing diversity.
Please do go through the report by John Samuels on "Genetically-engineered Bt brinjal and the implications for plant diversity - revisited", where I have referenced the above from (http://www.greenpeace.org/seasia/ph/PageFiles/415937/GE-Bt-brinjal-revisited.pdf, 1.3 MB).
Neha Saigal
Sustainable Agriculture Campaigner,
Greenpeace India,
60 Wellington Street.
Richmond Town,
Bangalore
India
e-mail:neha.saigal (at) greenpeace.org
[To contribute to this conference, send your message to [log in to unmask] For further information on this FAO Biotechnology Forum, see http://www.fao.org/biotech/biotech-forum/]
########################################################################
To unsubscribe from the Biotech-Room2-L list, click the following link:
https://listserv.fao.org/cgi-bin/wa?SUBED1=Biotech-Room2-L&A=1
|
|
|